Stay updated on SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial
Sign up to get notified when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.

Latest updates to the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor update to the page’s versioning information without altering study details or visible content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new page revision entry (v3.6.4) was added and the previous revision (v3.6.3) was removed, updating the page's revision history.SummaryDifference0.1%

- Check51 days agoChange DetectedStudy documents revision label updated to v3.6.3 from v3.6.2. This reflects a newer version of the materials and does not modify the study content.SummaryDifference0.1%

- Check58 days agoChange DetectedThe page now displays Revision: v3.6.2 instead of Revision: v3.6.0. This indicates a software update to the site rather than changes to the study content.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page introduces new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and removes the Intervention/Treatment heading, while the revision tag updates to v3.6.0; the Study Details now shows that recruitment is closed.SummaryDifference0.4%

- Check79 days agoChange DetectedThe page now displays a new Revision: v3.5.5 tag, indicating the latest version of the page template/documentation. This update does not alter the study details, eligibility criteria, or outputs shown to users.SummaryDifference0.1%

Stay in the know with updates to SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.